Expanding equitable access to medicines

The US pharmaceutical industry is at critical policy crossroads, facing a wave of changes that could significantly alter pricing structures, market access dynamics, and global strategy. In this timely webinar, Simon-Kucher’s pharma experts will examine the implications of recent and proposed Presidential executive orders, the strategic consequences of tariff measures for pharmaceuticals and the po